Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Watchlist Manager
Zylox-Tonbridge Medical Technology Co Ltd Logo
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Watchlist
Price: 16.8 HKD -3.11% Market Closed
Market Cap: 5.5B HKD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Zylox-Tonbridge Medical Technology Co Ltd stock under the Base Case scenario is 6.84 HKD. Compared to the current market price of 16.8 HKD, Zylox-Tonbridge Medical Technology Co Ltd is Overvalued by 59%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6.84 HKD
Overvaluation 59%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.6
P/S
P/S
Price to Sales
6.6
vs History
48
vs Industry
19
Median 3Y
7.9
Median 5Y
6.4
Industry
2.1
Forward
4.3
More Details
51.2
P/E
P/E
Price to Earnings
51.2
vs History
12
vs Industry
2
Median 3Y
-19.6
Median 5Y
-26.4
Industry
21.5
Forward
32.2
More Details
23.2
P/OCF
P/OCF
Price to OCF
23.2
vs History
12
vs Industry
17
Median 3Y
-24.5
Median 5Y
-29
Industry
13.2
More Details
63.1
P/FCFE
P/FCFE
Price to FCFE
63.1
vs History
0
vs Industry
8
Median 3Y
-13.3
Median 5Y
-14
Industry
18.8
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
14
vs Industry
51
Median 3Y
1.1
Median 5Y
1.1
Industry
2
More Details
5.2
EV/S
EV/S
Enterprise Value to Sales
5.2
vs History
14
vs Industry
22
Median 3Y
3.3
Median 5Y
3.1
Industry
2.2
Forward
3.4
More Details
7.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.2
vs History
12
vs Industry
29
Median 3Y
4.5
Median 5Y
4.4
Industry
4.6
More Details
111.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
111.5
vs History
0
vs Industry
57
Median 3Y
-7.2
Median 5Y
-11.1
Industry
11.4
Forward
21.3
More Details
111.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
111.5
vs History
0
vs Industry
52
Median 3Y
-7
Median 5Y
-8.7
Industry
15.4
Forward
38.8
More Details
18.3
EV/OCF
EV/OCF
Enterprise Value to OCF
18.3
vs History
2
vs Industry
25
Median 3Y
-1.6
Median 5Y
-4
Industry
13
More Details
178.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
178.2
vs History
0
vs Industry
3
Median 3Y
-3
Median 5Y
-5.5
Industry
16.5
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
19
vs Industry
44
Median 3Y
1.1
Median 5Y
1.2
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Zylox-Tonbridge Medical Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
5.5B HKD 6.6 51.2 111.5 111.5
US
Abbott Laboratories
NYSE:ABT
224.4B USD 5.3 16.7 22.4 32.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
171.4B USD 20.5 73.8 57.1 69.2
US
Boston Scientific Corp
NYSE:BSX
140.2B USD 8.4 75.6 34.7 48.9
US
Stryker Corp
NYSE:SYK
131.3B USD 5.8 43.9 22.8 27.5
IE
Medtronic PLC
NYSE:MDT
105.7B USD 3.2 24.8 13.3 18.8
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD 2.8 33.1 14.2 25.5
DE
Siemens Healthineers AG
XETRA:SHL
50.4B EUR 2.2 25.4 14.8 21.1
US
Edwards Lifesciences Corp
NYSE:EW
41.6B USD 7.7 10 23.4 25.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
258.6B CNY 7 20.9 18.1 18.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
32.8B USD 8.4 37 26.3 29.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 247,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.